Multiple Sclerosis International Federation

 
 
Research
Donate advanced search
print version print this page
 

inside
Research:

 

  Interferon beta-1a slows progression of brain atrophy in relapsing-remitting multiple sclerosis predominantly by reducing gray matter atrophy.

summary: The authors evaluated the impact of Interferon-beta on progression of brain atrophy in people with MS and found that this treatment slowed it down over a three-year period.

authors: Zivadinov R, Locatelli L, Cookfair D, Srinivasaraghavan B, Bertolotto A, Ukmar M, Bratina A, Maggiore C, Bosco A, Grop A, Catalan M, Zorzon M.

source: Mult Scler. 2007 May;13(4):490-501.

weblink: click here

category: Clinical Trials and Therapeutics

related research news: click here

glossary:

    Atrophy
    Brain
    Interferon
    Multiple sclerosis
    Relapsing/remitting MS
    Sclerosis
Copyright &<br>Link Policy Copyright &
Link Policy
Privacy Policy Privacy Policy back to top
Disclaimer Disclaimer Acknowledgements Acknowledgements
back to top  back to top  
Email Update Email Update Edit User Details Edit User Details Feedback Feedback Glossary Glossary Site Map Site Map
Back to top Back to top